2018 SC HIV, STD and Viral Hepatitis Conference (Columbia, SC)

South Carolina HIV, STD and Viral Hepatitis Conference
October 24 & 25, 2018
Columbia Metropolitan Convention Center
1101 Lincoln Street
Columbia, South Carolina 29201

To register for the conference online, please visit www.midcarolinaahec.org.

To register for the conference via mail, please follow the instructions on the conference website, www.schiv-stdconference.org.

The SC HIV, STD and Viral Hepatitis Conference is designed for nurse practitioners, physician assistants, nurses, other clinicians, HIV/STD/Viral Hepatitis educators, social workers, case managers, public health professionals, pharmacists, other service providers, teachers, students, people living with HIV/AIDS and other interested community members. The mission for this interdisciplinary conference is to provide opportunities for professionals and community members to engage in dialogue and share past successes, discuss current practices and interventions, as well as address emerging issues and trends.

A total of 9 of the concurrent sessions are ACPE-accredited for pharmacists, and pharmacists may claim a maximum of 6.0 live contact hours (0.6 CEUs) of knowledge-based continuing pharmacy education.

Please see below to view the details of each session accredited for pharmacists, or view the Learning Objectives for Pharmacists document within the program brochure by clicking here.

Date: Oct 24, 2018 08:00 AM - Oct 25, 2018 02:45 PM

CE Hours

9.00

CE Units

0.900

Activity Type

Knowledge

Target Audience(s)

Pharmacists

Accreditation(s)

The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

Requirements for CE Credit

Participants must sign in upon arrival and have attendance verified.

To claim credit for this activity, participants must complete the online program evaluation and must update their accounts to properly reflect their month/day of birth and correct NABP e-Profile ID. To register with NABP or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site.

Credit that is claimed greater than 60 days from the date of the program will be automatically rejected by the CPE Monitor. Claiming credit within 30 days of the live program will ensure that any issues with transmission to the CPE Monitor can be rectified in advance of the 60-day deadline. If you would like a paper statement of credit, you may print an individual statement or a transcript from your NABP e-Profile.

Wed, Oct 24, 2018

Present and future of monoclonal antibody therapy in HIV management

At the completion of this activity, the participant will be able to:

Describe the mechanism of monoclonal antibody therapy in HIV treatment
Identify the potential areas for monoclonal antibody therapy in patients with HIV
Recognize the recently approved monoclonal antibody and its place in HIV management

Speaker(s)/Author(s)

Jeannette Bouchard, PharmD, BCIDP
Clinical Infectious Diseases/Antimicrobial Stewardship Pharmacist, WakeMed Health & Hospitals

Activity Number

0062-9999-18-139-L01-P

Date: 10/24/18

Time: 10:40 AM - 11:40 AM

CE Hours

1.00

Pre-exposure prophylaxis for the prevention of HIV in women

At the completion of this activity, the participant will be able to:

Summarize the data that supports the use of PrEP in women at risk for HIV infection
Review the current epidemiology of HIV infection among U.S. women
Provide evidence for the use of PrEP among pregnant and postpartum women

Speaker(s)/Author(s)

Gweneth B. Lazenby, MD, MSCR
Associate Professor, Department of OB/GYN, MUSC College of Medicine

Activity Number

0062-9999-18-140-L01-P

Date: 10/24/18

Time: 11:50 AM - 12:50 PM

CE Hours

1.00

Neurosyphilis–A Review of Syphilis in SC and Unique Presentations

At the completion of this activity, the participant will be able to:

Describe the presence of syphilis in South Carolina
Discuss the presentation of and high morbidity associated with neurosyphilis
Review the effectiveness of treatments for neurosyphilis and unique syphilis cases

Speaker(s)/Author(s)

Kamla Devi Sanasi-Bhola, MD
Clinical Assistant Professor of Internal Medicine, UofSC School of Medicine

Activity Number

0062-9999-18-141-L01-P

Date: 10/24/18

Time: 02:40 PM - 03:40 PM

CE Hours

1.00

Hepatitis C Treatment Update

At the completion of this activity, the participant will be able to:

Discuss the newest hepatitis C testing recommendations
Discuss the hepatitis C treatment guidelines

Speaker(s)/Author(s)

Divya Ahuja, MD, MCRP
Associate Professor of Clinical Internal Medicine; UofSC School of Medicine

Activity Number

0062-9999-18-142-L01-P

Date: 10/24/18

Time: 02:40 PM - 03:40 PM

CE Hours

1.00

Hepatitis C Management in Special Populations: 2018 Update

At the completion of this activity, the participant will be able to:

Describe the treatment landscape for a patient with a history of IVDU
Discuss current and future treatment options in HCV infected pregnant women and children
Identify drug-drug interactions applicable to the HIV co-infected individual

Speaker(s)/Author(s)

Caroline Derrick, PharmD, BCPS
Infectious Diseases Clinical Pharmacist, UofSC School of Medicine, Department of Internal Medicine, Prisma Health - Midlands

Activity Number

0062-9999-18-144-L01-P

Date: 10/24/18

Time: 03:50 PM - 04:50 PM

CE Hours

1.00

Integrating Transgender Care in the Primary Care Setting

At the completion of this activity, the participant will be able to:

Recognize barriers that transgender individuals encounter when accessing primary care
Identify tools to feel comfortable caring for transgender and nonconforming patients

Speaker(s)/Author(s)

Ada D. Stewart, RPh, MD, FAAFP, AAHIVS, HMDC
President of the American Academy of Family Physicians, Cooperative Health

Activity Number

0062-9999-18-143-L04-P

Date: 10/24/18

Time: 03:50 PM - 04:50 PM

CE Hours

1.00

Thu, Oct 25, 2018

HIV Update 2018

At the completion of this activity, the participant will be able to:

Describe changes to HIV guideline recommendations
Provide information on new HIV medications
Discuss top research findings in HIV

Speaker(s)/Author(s)

Sharon Weissman, MD
Professor of Clinical Medicine, Division of Infectious Diseases University of South Carolina, Chair, Department of Medicine Prisma Health Midlands

Activity Number

0062-9999-18-145-L01-P

Date: 10/25/18

Time: 10:40 AM - 11:40 AM

CE Hours

1.00

HIV and OTCs - is natural always safe?

At the completion of this activity, the participant will be able to:

Review indications for commonly used dietary supplements and micronutrients
Recognize benefits and/or risks of the use of dietary supplements for patients living with HIV
Determine if the over-the-counter product is acceptable and safe for use, given a patient case

Speaker(s)/Author(s)

Stephanie Kirk, PharmD, CDCES
Assistant Professor, MUSC Division of Infectious Diseases

Activity Number

0062-9999-18-146-L01-P

Date: 10/25/18

Time: 10:40 AM - 11:40 AM

CE Hours

1.00

At the Crossroads of Hepatitis B Virus Infection: What's Ahead in 2018?

At the completion of this activity, the participant will be able to:

Review changes/updates to 2018 HBV guidelines
Review new medications approved or in development

Speaker(s)/Author(s)

Bryan L. Love, PharmD, BCPS
Clinical Associate Professor, USC College of Pharmacy

Activity Number

0062-9999-18-147-L01-P

Date: 10/25/18

Time: 11:50 AM - 12:50 PM

CE Hours

1.00